Skip to content
← Study library

NCT00828516 · REGISTRY CONDITION SEARCH

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

Found through the registry condition index, not selected as a treatment recommendation. This discovery collection was restricted to studies with posted results.

Phase
NA
Status at capture
COMPLETED
Registry last update
2013-01-17

RATIONALE: Acupuncture and moxibustion may improve well-being and quality of life in patients with lymphedema caused by breast cancer or head, neck, and throat cancer. PURPOSE: This clinical trial is studying how well acupuncture given together with moxibustion works in improving well-being and quality of life in patients with breast cancer or head, neck, and throat cancer who are undergoing standard treatment for lymphedema.

Open the original ClinicalTrials.gov record → · Download preserved record

What did the study report?

Outcomes, safety and baseline populations are separate source sections. Quality-of-life measures appear under their original outcome titles.

Who could take part
eligibility Criteria
INCLUSION CRITERIA: * male or female patients with either breast or head and neck cancer * diagnosis of mild to moderate uncomplicated lymphoedema * age 18 or over * under the care of the lymphoedema service for at leas: * two months (head and neck cancer patients) * three months (breast cancer patients) * no active cancer disease * at least 3 months since prior active cancer treatment (surgery, radiotherapy, chemotherapy, intravenous treatment) * more than 6 months since prior acupuncture treatment * concurrent adjuvant hormonal therapy allowed * concurrent anti-depressant medication allowed provided there has been no change in prescription or dosing within the past 3 months and patient intends to remain on the medication for the duration of study treatment and follow-up * Able to understand and communicate in English * Able to travel to the Lynda Jackson Macmillan Centre for treatment * Able to attend treatment once weekly for at least 7 consecutive weeks * Able to complete outcome measures EXCLUSION CRITERIA: * bilateral breast cancer * advanced cancer disease
healthy Volunteers
false
minimum Age
18 Years
sex
ALL
std Ages
  1. ADULT
  2. OLDER_ADULT
Treatment arms and interventions
arm Groups
  1. description
    Acupuncture and moxibustion, individualised according to participant priorities, delivered once weekly for 7 treatments (Series 1) followed by 6 treatments (Series 2) if participant wishes to continue treatment
    intervention Names
    1. Other: Acupuncture and moxibustion
    label
    Usual treatment plus acupuncture
    type
    EXPERIMENTAL
interventions
  1. arm Group Labels
    1. Usual treatment plus acupuncture
    description
    Acupuncture is a form of traditional east Asian medicine that uses needles inserted superficially under the skin to stimulate sites on the body known as acupuncture points. Traditional practice encompasses moxibustion, the application of heat (usually from the smouldering herb artemisia vulgaris or mugwort) to stimulate the points by warming them.
    name
    Acupuncture and moxibustion
    type
    OTHER
Study design
allocation
NA
intervention Model
SINGLE_GROUP
masking Info
masking
NONE
primary Purpose
SUPPORTIVE_CARE
Enrollment
count
56
type
ACTUAL
Registered outcome plans (not posted results)
primary Outcomes
  1. description
    MYMOP is a questionnaire widely used for evaluating interventions based on holistic and participative principles. It enables respondants to specify and measure the treatment outcomes that are important to them.
    measure
    Change From Baseline in Patient-specified and Reported Symptoms on the Measure Yourself Medical Outcome Profile (MYMOP)
    time Frame
    Before 7th acupuncture treatment
  2. description
    MYMOP is a questionnaire widely used for evaluating interventions based on holistic and participative principles. It enables respondants to specify and measure the treatment outcomes that are important to them.
    measure
    Change From Baseline in Patient-specified and Reported Symptoms on the Measure Yourself Medical Outcome Profile
    time Frame
    Before the 13th acupuncture treatment
Full study description
brief Summary
RATIONALE: Acupuncture and moxibustion may improve well-being and quality of life in patients with lymphedema caused by breast cancer or head, neck, and throat cancer. PURPOSE: This clinical trial is studying how well acupuncture given together with moxibustion works in improving well-being and quality of life in patients with breast cancer or head, neck, and throat cancer who are undergoing standard treatment for lymphedema.
detailed Description
OBJECTIVES: * To test the acupuncture and moxibustion treatment strategies to obtain a first measure of response for the approach(es) used in patients with breast cancer or head, neck, and throat cancer undergoing standard treatment for secondary lymphedema. * To assess whether this treatment is an acceptable intervention to cancer patients with secondary lymphedema and to their health care professionals. * To disseminate the data to begin to build the evidence base for using this treatment in the management of lymphedema. OUTLINE: Patients undergo acupuncture and moxibustion therapy once weekly for 7 treatment (Series 1). After completion of therapy, patients may choose to continue treatment for an additional 6 treatments (Series 2). Patients complete a set of 4 questionnaires (i.e., sociodemographic, Short-Form-36, Positive and Negative Affect Scale (PANAS), and Measure Yourself Medical Outcome Profile (MYMOP)) at the first treatment and then periodically during study. Patients also complete a series of follow-up questionnaires designed to elicit feedback about their acupuncture experience. After completion of study treatment, patients are followed at 1 and 3 months.
Source references
references
  1. citation
    de Valois B and Peckham R (2011) Treating the person and not the disease: acupuncture in the management of cancer treatment-related lymphoedema. European Journal of Oriental Medicine, 6(6), 37-49.
    type
    BACKGROUND
  2. citation
    de Valois BA, Young TE, Melsome E. Assessing the feasibility of using acupuncture and moxibustion to improve quality of life for cancer survivors with upper body lymphoedema. Eur J Oncol Nurs. 2012 Jul;16(3):301-9. doi: 10.1016/j.ejon.2011.07.005. Epub 2011 Sep 13.
    pmid
    21917515
    type
    RESULT
  3. citation
    de Valois B, Young T, Melsome E (2011) Acupuncture in lymphoedema management: a feasibility study. Journal of Lymphoedema. 6(2) 20-31.
    type
    RESULT
Source notices and limitations
    Discovery and provenance
    1. release id
      ctgov-registry-1336d216cbd1bbff780dac70
      edge id
      nct-edge-2853fe1b515f3e658e4b
      requested nct id
      NCT00828516
      primary nct id
      NCT00828516
      source kind
      ctgov_condition_query
      source record id
      Source null
      source file sha256
      fd31a95088dd8ee475e2862bffd724180f0c754cf3f0e892cba5b448df424980
      payload sha256
      59508fe155593a5c0a040981111f742d2d852861e77e202f4f4e5dee6ca660c0
      payload
      clinical indication matching status
      condition_index_match_asserted_by_registry_not_reviewed
      end exclusive
      true
      id
      nct-edge-2853fe1b515f3e658e4b
      link basis
      returned_by_explicit_condition_and_posted_results_filter_query
      nct id
      NCT00828516
      occurrences
      1. context exact
        NCT00828516
        end
        11
        exact text
        NCT00828516
        start
        0
      offset unit
      unicode_code_points
      query cond
      Laryngeal Cancer
      query disease state id
      ds-laryngeal-cancer
      source file
      /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-laryngeal-cancer-000.json
      source file sha256
      fd31a95088dd8ee475e2862bffd724180f0c754cf3f0e892cba5b448df424980
      source json pointer
      /studies/77/protocolSection/identificationModule/nctId
      source kind
      ctgov_condition_query
      source record id
      Source null
      source string basis
      parsed_JSON_string_unmodified
      source string sha256
      d5b71b25b9abe11703c646ff8458667ab1285a6a72b551a40924d9b6737e014b
    2. release id
      ctgov-registry-1336d216cbd1bbff780dac70
      edge id
      nct-edge-6568205486b9c583c046
      requested nct id
      NCT00828516
      primary nct id
      NCT00828516
      source kind
      ctgov_condition_query
      source record id
      Source null
      source file sha256
      38e97f6c23d7b292911d062dea3fc0dffbdcbde03aae232fe8d067fdd28034c9
      payload sha256
      eeee137b9cea5977be453f7c175de763cb2647a44278b56bb6e29ac7847f1a65
      payload
      clinical indication matching status
      condition_index_match_asserted_by_registry_not_reviewed
      end exclusive
      true
      id
      nct-edge-6568205486b9c583c046
      link basis
      returned_by_explicit_condition_and_posted_results_filter_query
      nct id
      NCT00828516
      occurrences
      1. context exact
        NCT00828516
        end
        11
        exact text
        NCT00828516
        start
        0
      offset unit
      unicode_code_points
      query cond
      Salivary Gland Cancer
      query disease state id
      ds-salivary-gland-cancer
      source file
      /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-salivary-gland-cancer-000.json
      source file sha256
      38e97f6c23d7b292911d062dea3fc0dffbdcbde03aae232fe8d067fdd28034c9
      source json pointer
      /studies/38/protocolSection/identificationModule/nctId
      source kind
      ctgov_condition_query
      source record id
      Source null
      source string basis
      parsed_JSON_string_unmodified
      source string sha256
      d5b71b25b9abe11703c646ff8458667ab1285a6a72b551a40924d9b6737e014b
    3. release id
      ctgov-registry-1336d216cbd1bbff780dac70
      edge id
      nct-edge-9f94a9b625c2d9702399
      requested nct id
      NCT00828516
      primary nct id
      NCT00828516
      source kind
      ctgov_condition_query
      source record id
      Source null
      source file sha256
      2598159af8c743c394b8ddc26022f84d68183b09edf878a8af96c931226e93a5
      payload sha256
      d671943cf4accdc4b33be38eea219a16d84cb90e79cc3d9e85835210ac84f1f8
      payload
      clinical indication matching status
      condition_index_match_asserted_by_registry_not_reviewed
      end exclusive
      true
      id
      nct-edge-9f94a9b625c2d9702399
      link basis
      returned_by_explicit_condition_and_posted_results_filter_query
      nct id
      NCT00828516
      occurrences
      1. context exact
        NCT00828516
        end
        11
        exact text
        NCT00828516
        start
        0
      offset unit
      unicode_code_points
      query cond
      Metastatic Squamous Neck Cancer With Occult Primary
      query disease state id
      ds-metastatic-squamous-neck-cancer-with-occult-primary
      source file
      /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-metastatic-squamous-neck-cancer-with-occult-primary-000.json
      source file sha256
      2598159af8c743c394b8ddc26022f84d68183b09edf878a8af96c931226e93a5
      source json pointer
      /studies/17/protocolSection/identificationModule/nctId
      source kind
      ctgov_condition_query
      source record id
      Source null
      source string basis
      parsed_JSON_string_unmodified
      source string sha256
      d5b71b25b9abe11703c646ff8458667ab1285a6a72b551a40924d9b6737e014b
    4. release id
      ctgov-registry-1336d216cbd1bbff780dac70
      edge id
      nct-edge-ac64561fc97509f4fb29
      requested nct id
      NCT00828516
      primary nct id
      NCT00828516
      source kind
      ctgov_condition_query
      source record id
      Source null
      source file sha256
      cd92c144c33b33e75a38086ce6cbd6e62d34b7ba84c72dacac16e6781439e40e
      payload sha256
      b1fd314f11afc646f9ac197e1a1737395e0da69cae1223e62f8ff4ef9873e9e4
      payload
      clinical indication matching status
      condition_index_match_asserted_by_registry_not_reviewed
      end exclusive
      true
      id
      nct-edge-ac64561fc97509f4fb29
      link basis
      returned_by_explicit_condition_and_posted_results_filter_query
      nct id
      NCT00828516
      occurrences
      1. context exact
        NCT00828516
        end
        11
        exact text
        NCT00828516
        start
        0
      offset unit
      unicode_code_points
      query cond
      Hypopharyngeal Cancer
      query disease state id
      ds-hypopharyngeal-cancer
      source file
      /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-hypopharyngeal-cancer-000.json
      source file sha256
      cd92c144c33b33e75a38086ce6cbd6e62d34b7ba84c72dacac16e6781439e40e
      source json pointer
      /studies/60/protocolSection/identificationModule/nctId
      source kind
      ctgov_condition_query
      source record id
      Source null
      source string basis
      parsed_JSON_string_unmodified
      source string sha256
      d5b71b25b9abe11703c646ff8458667ab1285a6a72b551a40924d9b6737e014b

    Preserved source evidence · Not medical advice